Report overview
Inflammation of liver causes hepatitis. Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chronic hepatitis infection. Chronic hepatitis C is diagnosed by liver biopsy and blood tests.
This report contains market size and forecasts of Hepatitis C Virus (HCV) in Global, including the following market information:
Global Hepatitis C Virus (HCV) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Hepatitis C Virus (HCV) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Therapeutics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hepatitis C Virus (HCV) include Merck, Genentech, Vertex, Janssen and Medivir, F. Hoffmann-La Roche, Bristol Myers Squibb, AbbVie and Gilead Sciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hepatitis C Virus (HCV) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis C Virus (HCV) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hepatitis C Virus (HCV) Market Segment Percentages, by Type, 2021 (%)
Therapeutics
Vaccine
Global Hepatitis C Virus (HCV) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Hepatitis C Virus (HCV) Market Segment Percentages, by Application, 2021 (%)
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Global Hepatitis C Virus (HCV) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Hepatitis C Virus (HCV) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatitis C Virus (HCV) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Hepatitis C Virus (HCV) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Genentech
Vertex
Janssen and Medivir
F. Hoffmann-La Roche
Bristol Myers Squibb
AbbVie
Gilead Sciences
